Community News

IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Urovant Sciences to Ring the Nasdaq Stock Market Opening Bell

CULVER CITY, Calif.--(BUSINESS WIRE)--Patrick Soon-Shiong, M.D., Chairman and CEO of NantKwest, Inc. and ImmunityBio, Inc. presented an update of the Cancer Breakthrough 2020 Initiative (the “Initiative”) and findings on the preliminary safety and early signals of efficacy in Phase 1 and 2 trials for multiple tumor types at the 2020 J.P. Morgan Healthcare Conference on January 14, 2020 in San Francisco. “We hypothesized that a common treatment protocol that harnesses both the […]

LOS ANGELES--(BUSINESS WIRE)--Surgical suite is the first hospital-based facility dedicated to eye surgery, equipped with cutting-edge technology for optimal patient outcome.

CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen Granted New EU Patent For Treating GI Mucositis

LOS ANGELES & WHIPPANY, N.J.--(BUSINESS WIRE)--Life Science company Bayer will host a full day workshop during The LAGRANT Foundation (TLF)’s 22nd Anniversary Scholarship Program at its facility in New Jersey on Wednesday, May 20, 2020. The workshop will be led by Raymond (Ray) F. Kerins Jr., Bayer’s senior vice president, head of Corporate Affairs. In his role, Kerins manages all communications, government relations, and philanthropy for the company. Previously, he was the vice […]

LOS ANGELES--(BUSINESS WIRE)--XS Shares to Begin Trading on the OTCQB Under the Symbol XSHLF

LOS ANGELES--(BUSINESS WIRE)--Cloudbreak Health, LLC, (“Cloudbreak”), a leading unified telemedicine and video medical interpretation solutions provider, officially launched its most advanced product offering to date, MarttiNext. The solution brings significant enhancement to the user experience with rock-solid network stability that enhances accessibility, scalability and reliability. “Hundreds of our large health system customers have made the transition to MarttiNext in […]

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (NASDAQ: MASI) today announced select preliminary results for the full-year ended December 28, 2019 and provided estimates for its full-year 2020 financial guidance. Preliminary Full-Year 2019 Results: Masimo expects that its product revenue for the full-year 2019 will range from $933 million to $936 million, which reflects reported growth of 12.4% to 12.8% and constant currency growth of 13.2% to 13.6%, respectively. The Company also expects

IRVINE, Calif. & CULVER CITY, Calif.--(BUSINESS WIRE)--Masimo and NantHealth announced the signing of a definitive agreement under which Masimo will acquire the Connected Care assets from NantHealth.

CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest Inc., (Nasdaq: NK), a clinical-stage natural killer cell-based therapeutics company, today announced results from their Phase 1 trial investigating a novel, first-in-human immunotherapy consisting of NantKwest’s off-the-shelf, PD-L1 tumor-targeted NK cells (NCT04050709). In addition, NantKwest and ImmunityBio, Inc., a privately held immunotherapy company, reported on a compassionate use expanded access IND combining the PD-L1-targeted NK […]

VANCOUVER, British Columbia & FOUNTAIN VALLEY, Calif.--(BUSINESS WIRE)-- #cancergenomics--Contextual Genomics, a leading cancer genomics company, and Lab Genomics, a personalized medicine company providing state of the art molecular genetic testing in Southern California, announced that they have signed an agreement enabling Lab Genomics to offer Contextual Genomics’ quality assured Next Generation Sequencing (NGS) based ctDNA cancer genomic testing to patients in Southern California […]

LOS ANGELES--(BUSINESS WIRE)--On Jan. 13, 2020, Puma Biotechnology released the slides that CEO Alan Auerbach will present at the J.P. Morgan Healthcare Conf. on Jan. 15.

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and fiscal year ended January 3, 2020. The Company expects fourth quarter and fiscal year net sales to increase approximately 25% and 21% over the prior year periods, respectively. Total net sales for the fourth quarter and fiscal year are expected to

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the Company has gained CE Mark approval for use of its ICL as a supplemental or “piggyback” lens in post-cataract IOL surgery patients (pseudophakics). A supplemental EVO ICL is placed in front of the cataract IOL lens in post-cataract patients just like the EVO ICL is placed […]

IRVINE, Calif.--(BUSINESS WIRE)---- $NVUS #otitismedia--Novus Therapeutics' OP0201 Phase 2a study C-006 enrollment to be completed in 1Q 2020 and data expected in 2Q 2020.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that CEO Shawn O'Connor will attend and present at the Needham 22nd Growth Conference in New York City on January 15, 2020.

IRVINE, Calif.--(BUSINESS WIRE)---- $NVUS #otitismedia--Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ALPHAEON Corporation (“ALPHAEON”), announced today that it has completed a reorganization to simplify its corporate structure. As a result of this reorganization the company has split into two business units, each of which will retain the same shareholder base that was in place prior to this split off. ALPHAEON has been renamed AEON Biopharma, Inc. (“AEON”), which will now focus on developing its proprietary botulinum toxin […]

LOS ANGELES--(BUSINESS WIRE)--On January 9, 2020, Puma Biotechnology reported inducement awards granted in December 2019 under Nasdaq Listing Rule 5635(c)(4).

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported record 1st quarter results for fiscal year 2020. Net revenues of $9.4 million increased 24.8%, or $1.9M, over 1QFY19.